Research location
Żyrardów
Poland
Advertisement
Research activity in Żyrardów
PolandCureCurrent currently publishes aggregate city-level research activity for this location: 15 trials and 15 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Żyrardów
15 linked trials · page 1 of 1AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes MedicationsNCT07797335 · 2026-08-24 · 1 site observation
RECRUITING
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation
RECRUITING
A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body WeightNCT07357766 · 2026-06-22 · 1 site observation
WITHDRAWN
AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose WeightNCT07400107 · 2026-05-20 · 1 site observation
NOT_YET_RECRUITING
Emp-Activity: Empagliflozin Functional CapacityNCT05350202 · 2022-12-18 · 1 site observation
COMPLETED
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateNCT01764997 · 2013-04-01 · 1 site observation
TERMINATED
Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) TestNCT01644734 · 2011-11-01 · 1 site observation
COMPLETED
Efficacy of NNC109-0012 in Subjects With Active Rheumatoid ArthritisNCT01282255 · 2011-02-01 · 1 site observation
COMPLETED
Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)NCT01264770 · 2011-01-01 · 1 site observation
TERMINATED
Evaluation of Long-term Safety and Effectiveness of Fostamatinib in the Treatment of Rheumatoid Arthritis (RA)NCT01242514 · 2011-01-01 · 1 site observation
TERMINATED
A Study to Evaluate the Safety and Efficacy of CCX354-C in Subjects With Rheumatoid Arthritis Partially Responsive to Methotrexate TherapyNCT01242917 · 2010-09-01 · 1 site observation
COMPLETED
Evaluation of Effectiveness of Two Dosing Regimens of Fostamatinib Compared to Placebo in Patients With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Not Responding.NCT01197521 · 2010-09-01 · 1 site observation
COMPLETED
Safety and Efficacy of AMG 827 in Subjects With RANCT01059448 · 2010-06-03 · 1 site observation
TERMINATED
A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702NCT00395577 · 2006-11-01 · 1 site observation
COMPLETED
Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702NCT00205478 · 2005-06-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.